New combo therapy aims to fight rectal cancer without radiation
NCT ID NCT06688786
Summary
This study is testing a new pre-surgery treatment for people with a common type of advanced rectal cancer. It combines standard chemotherapy with an immunotherapy drug, aiming to shrink tumors effectively without using radiation. The goal is to improve surgery outcomes while avoiding the side effects of radiation, which can harm long-term anal function and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED RECTAL CANCER (LARC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200092, China
Conditions
Explore the condition pages connected to this study.